摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(3-Methylphenyl)-2-morpholin-4-yl-2-thioxoacetamide | 635293-05-9

中文名称
——
中文别名
——
英文名称
N-(3-Methylphenyl)-2-morpholin-4-yl-2-thioxoacetamide
英文别名
N-(3-methylphenyl)-2-morpholin-4-yl-2-sulfanylideneacetamide
N-(3-Methylphenyl)-2-morpholin-4-yl-2-thioxoacetamide化学式
CAS
635293-05-9
化学式
C13H16N2O2S
mdl
——
分子量
264.348
InChiKey
ZOXPCTPOPMZBOG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    18
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    73.7
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    N-(3-Methylphenyl)-2-morpholin-4-yl-2-thioxoacetamide一水合肼 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 以71%的产率得到2-hydrazinyl-N-(3-methylphenyl)-2-thioxoacetamide
    参考文献:
    名称:
    新型甾体1,3,4-噻二嗪:雄激素受体阳性前列腺癌22Rv1细胞的合成和生物学评估。
    摘要:
    公开了一种对甾体的以前未知的螺合的和连接的1,3,4-噻二嗪衍生物具有选择性控制杂环化模式的灵活方法。(N-芳基氨基甲酰基)螺雄甾烯17,6'[1,3,4]噻二嗪和(N-芳基氨基甲酰基)17- [1',3',4']噻二嗪取代的雄烯酮是由新型杂类固醇制备的16 β,17 β -epoxypregnenolone和21 bromopregna -5,16-二烯-20-酮在良好至高产率通过用草氨酸硫代酰肼的治疗。筛选合成的化合物对人雄激素受体阳性前列腺癌细胞系22Rv1的抗增殖活性。大部分(N-芳基氨基甲酰基)17- [1',3',4']噻二嗪取代的雄烯酮显示出 比抗雄激素比卡鲁胺更好的抗增殖能力(IC 50 = 2.1–6.6 µM)。 在研究的系列中,IC 50 = 3.0μM的化合物7d和IC 50  = 2.1μM的化合物7j被证明是活性最高的。铅合成的化合物7j下调22Rv1细胞中AR
    DOI:
    10.1016/j.bioorg.2019.103142
  • 作为产物:
    参考文献:
    名称:
    新型甾体1,3,4-噻二嗪:雄激素受体阳性前列腺癌22Rv1细胞的合成和生物学评估。
    摘要:
    公开了一种对甾体的以前未知的螺合的和连接的1,3,4-噻二嗪衍生物具有选择性控制杂环化模式的灵活方法。(N-芳基氨基甲酰基)螺雄甾烯17,6'[1,3,4]噻二嗪和(N-芳基氨基甲酰基)17- [1',3',4']噻二嗪取代的雄烯酮是由新型杂类固醇制备的16 β,17 β -epoxypregnenolone和21 bromopregna -5,16-二烯-20-酮在良好至高产率通过用草氨酸硫代酰肼的治疗。筛选合成的化合物对人雄激素受体阳性前列腺癌细胞系22Rv1的抗增殖活性。大部分(N-芳基氨基甲酰基)17- [1',3',4']噻二嗪取代的雄烯酮显示出 比抗雄激素比卡鲁胺更好的抗增殖能力(IC 50 = 2.1–6.6 µM)。 在研究的系列中,IC 50 = 3.0μM的化合物7d和IC 50  = 2.1μM的化合物7j被证明是活性最高的。铅合成的化合物7j下调22Rv1细胞中AR
    DOI:
    10.1016/j.bioorg.2019.103142
点击查看最新优质反应信息

文献信息

  • Synthesis of Oxamic Acids Thiohydrazides and Carbamoyl-1,3,4-thiadiazoles
    作者:V. N. Yarovenko、A. V. Shirokov、O. N. Krupinova、I. V. Zavarzin、M. M. Krayushkin
    DOI:10.1023/b:rujo.0000010181.01921.77
    日期:2003.8
    A convenient preparation method was developed for oxamic acids thiohydrazides by reaction of alpha-chloroacetamides with a preliminary prepared solution of elemental sulfur and hydrazines. A series of carbamoyl-1,3,4-thiadiazole derivatives was obtained.
  • A Straightforward Approach toward Multifunctionalized Pyridazines via Imination/Electrocyclization
    作者:Alexander V. Komkov、Anna S. Komendantova、Leonid G. Menchikov、Elena I. Chernoburova、Yulia A. Volkova、Igor V. Zavarzin
    DOI:10.1021/acs.orglett.5b01718
    日期:2015.8.7
    A facile synthesis of functionalized 3-carbamide pyridazines starting from readily available chlorovinyl aldehydes and oxamic acid thiohydrazides via cascade imination/electrocyclization is reported. In the presence of p-toluenesulfuric acid, various ketones have been efficiently incorporated into the pyridazine derivatives through a two-step sequence involving a VilsmeierHaack reaction and imination. The synthetic value of this method has been demonstrated by efficient synthesis of steroidal pyridazines.
  • Novel agonists of free fatty acid receptor 1 (GPR40) based on 3-(1,3,4-thiadiazol-2-yl)propanoic acid scaffold
    作者:Mikhail Krasavin、Alexey Lukin、Nikolay Zhurilo、Alexey Kovalenko、Ihor Zahanich、Sergey Zozulya
    DOI:10.3109/14756366.2016.1142984
    日期:2016.11.1
    1,3,4-Thiadiazole was explored as a more polar, heterocyclic replacement for the phenyl ring in the 3-arylpropionic acid pharmacophore present in the majority of GPR40 agonists. Out of 13 compounds synthesized using a flexible, three-step protocol (involving no chromatographic purification), four compounds were confirmed to activate the target in micromolar concentration range. While the potency of the series should be subject of further optimization, the remarkable aqueous solubility and microsomal stability observed for the lead compound (8g) apparently attests to this new scaffold's high promise in the GPR40 agonist field.
  • Synthesis of Carbamoyl-Containing N,S-Heterocyclic Compounds
    作者:V. N. Yarovenko、A. A. Es'kov、I. V. Zavarzin、E. I. Chernoburova、A. Yu. Martynkin、M. M. Krayuskin
    DOI:10.1080/10426500307911
    日期:2003.6
    Monothioxamides unsubstituted at the thioamidic nitrogen atom were obtained by the reaction of NS-morpholino-NO-R-thioxamides with ammonia. Carbampyl-containing 5-phenylcarbamoyl-1,2,4-dithiazoles, 6-phenylcarbamoyl-5,6-dihydro-[1,2,4,5]-dithiadiazin-3-one, and 5-phenylcarbainoyl-2-oxy-1,3,4-thiadiazole were synthesized by the reaction of monothioxamides or thiohydrazides of oxamic acids with chlorocarbonylsulfenyl chloride.
  • Novel steroidal 1,3,4-thiadiazines: Synthesis and biological evaluation in androgen receptor-positive prostate cancer 22Rv1 cells
    作者:Anna S. Komendantova、Alexander M. Scherbakov、Alexander V. Komkov、Viktoriya V. Chertkova、Alexey O. Gudovanniy、Elena I. Chernoburova、Danila V. Sorokin、Yaraslau U. Dzichenka、Valerii Z. Shirinian、Yulia A. Volkova、Igor V. Zavarzin
    DOI:10.1016/j.bioorg.2019.103142
    日期:2019.10
    A flexible approach to previously unknown spirofused and linked 1,3,4-thiadiazine derivatives of steroids with selective control of heterocyclization patterns is disclosed. (N-Arylcarbamoyl)spiroandrostene-17,6′ [1,3,4]thiadiazines and (N-arylcarbamoyl)17-[1′,3′,4′]thiadiazine-substituted androstenes, novel types of heterosteroids, were prepared from 16β,17β-epoxypregnenolone and 21-bromopregna-5,16-dien-20-one
    公开了一种对甾体的以前未知的螺合的和连接的1,3,4-噻二嗪衍生物具有选择性控制杂环化模式的灵活方法。(N-芳基氨基甲酰基)螺雄甾烯17,6'[1,3,4]噻二嗪和(N-芳基氨基甲酰基)17- [1',3',4']噻二嗪取代的雄烯酮是由新型杂类固醇制备的16 β,17 β -epoxypregnenolone和21 bromopregna -5,16-二烯-20-酮在良好至高产率通过用草氨酸硫代酰肼的治疗。筛选合成的化合物对人雄激素受体阳性前列腺癌细胞系22Rv1的抗增殖活性。大部分(N-芳基氨基甲酰基)17- [1',3',4']噻二嗪取代的雄烯酮显示出 比抗雄激素比卡鲁胺更好的抗增殖能力(IC 50 = 2.1–6.6 µM)。 在研究的系列中,IC 50 = 3.0μM的化合物7d和IC 50  = 2.1μM的化合物7j被证明是活性最高的。铅合成的化合物7j下调22Rv1细胞中AR
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物